VYGR vs. DAWN, RCKT, PHVS, CDMO, COGT, OCS, OPT, PRTA, MRVI, and CRON
Should you be buying Voyager Therapeutics stock or one of its competitors? The main competitors of Voyager Therapeutics include Day One Biopharmaceuticals (DAWN), Rocket Pharmaceuticals (RCKT), Pharvaris (PHVS), Avid Bioservices (CDMO), Cogent Biosciences (COGT), Oculis (OCS), Opthea (OPT), Prothena (PRTA), Maravai LifeSciences (MRVI), and Cronos Group (CRON). These companies are all part of the "pharmaceutical products" industry.
Voyager Therapeutics vs.
Day One Biopharmaceuticals (NASDAQ:DAWN) and Voyager Therapeutics (NASDAQ:VYGR) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, community ranking, earnings, media sentiment, profitability, analyst recommendations, institutional ownership, valuation and dividends.
In the previous week, Day One Biopharmaceuticals had 7 more articles in the media than Voyager Therapeutics. MarketBeat recorded 11 mentions for Day One Biopharmaceuticals and 4 mentions for Voyager Therapeutics. Voyager Therapeutics' average media sentiment score of 0.20 beat Day One Biopharmaceuticals' score of 0.12 indicating that Voyager Therapeutics is being referred to more favorably in the news media.
Voyager Therapeutics received 344 more outperform votes than Day One Biopharmaceuticals when rated by MarketBeat users. However, 69.33% of users gave Day One Biopharmaceuticals an outperform vote while only 67.81% of users gave Voyager Therapeutics an outperform vote.
Voyager Therapeutics has a net margin of 15.80% compared to Day One Biopharmaceuticals' net margin of 0.00%. Voyager Therapeutics' return on equity of 8.33% beat Day One Biopharmaceuticals' return on equity.
87.9% of Day One Biopharmaceuticals shares are held by institutional investors. Comparatively, 48.0% of Voyager Therapeutics shares are held by institutional investors. 8.4% of Day One Biopharmaceuticals shares are held by insiders. Comparatively, 4.5% of Voyager Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Voyager Therapeutics has higher revenue and earnings than Day One Biopharmaceuticals. Day One Biopharmaceuticals is trading at a lower price-to-earnings ratio than Voyager Therapeutics, indicating that it is currently the more affordable of the two stocks.
Day One Biopharmaceuticals has a beta of -1.38, indicating that its share price is 238% less volatile than the S&P 500. Comparatively, Voyager Therapeutics has a beta of 0.99, indicating that its share price is 1% less volatile than the S&P 500.
Day One Biopharmaceuticals presently has a consensus price target of $34.57, indicating a potential upside of 328.39%. Voyager Therapeutics has a consensus price target of $15.72, indicating a potential upside of 276.89%. Given Day One Biopharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe Day One Biopharmaceuticals is more favorable than Voyager Therapeutics.
Summary
Voyager Therapeutics beats Day One Biopharmaceuticals on 11 of the 18 factors compared between the two stocks.
Get Voyager Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for VYGR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Voyager Therapeutics Competitors List
Related Companies and Tools
This page (NASDAQ:VYGR) was last updated on 3/11/2025 by MarketBeat.com Staff
Free VYGR Stock Alerts